tiprankstipranks
Advertisement
Advertisement
Merck Animal Health to acquire Targan
PremiumThe FlyMerck Animal Health to acquire Targan
11d ago
Merck, Gilead announce discontinuation of Phase 3 KEYNOTE-D46/EVOKE-03 study
Premium
The Fly
Merck, Gilead announce discontinuation of Phase 3 KEYNOTE-D46/EVOKE-03 study
13d ago
Acting FDA head vows to block political interference, Endpoint News says
Premium
The Fly
Acting FDA head vows to block political interference, Endpoint News says
17d ago
Hold Rating Reiterated on Merck as sac-TMT Phase 3 Win Offsets Full Valuation; $125 Price Target Unchanged
PremiumRatingsHold Rating Reiterated on Merck as sac-TMT Phase 3 Win Offsets Full Valuation; $125 Price Target Unchanged
21d ago
Merck says FDA grants Breakthrough Therapy Designation for calderasib
Premium
The Fly
Merck says FDA grants Breakthrough Therapy Designation for calderasib
24d ago
Merck Shareholders Back Board, Pay and Auditor Ratification
Premium
Company Announcements
Merck Shareholders Back Board, Pay and Auditor Ratification
24d ago
Kelun-Biotech to present sac-TMT, lunbotinib fumarate studies at ASCO
PremiumThe FlyKelun-Biotech to present sac-TMT, lunbotinib fumarate studies at ASCO
1M ago
Trump Trade: Trump announces expansion of TrumpRx.gov
Premium
The Fly
Trump Trade: Trump announces expansion of TrumpRx.gov
1M ago
Exelixis announces clinical development collaboration with Merck
Premium
The Fly
Exelixis announces clinical development collaboration with Merck
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100